Journey Strategic Wealth’s CVS Health CVS Stock Holding History

Journey Strategic Wealth’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$707K	Buy	9,844 +3,190	+48%	+$246K	0.02%	262
2025 Q4	$528K	Buy	6,654 +203	+3%	+$16K	0.01%	301
2025 Q3	$486K	Buy	6,451 +2,612	+68%	+$179K	0.01%	304
2025 Q2	$265K	Buy	+3,839	New	+$252K	0.01%	489
2023 Q3	–	Sell	-3,452	Closed	-$239K	–	207
2023 Q2	$239K	Sell	3,452 -2,203	-39%	-$157K	0.01%	149
2023 Q1	$420K	Buy	5,655 +1,111	+24%	+$93.2K	0.04%	118
2022 Q4	$424K	Buy	4,544 +374	+9%	+$36.1K	0.05%	116
2022 Q3	$398K	Buy	4,170 +1,889	+83%	+$187K	0.05%	82
2022 Q2	$211K	Sell	2,281 -1,734	-43%	-$169K	0.03%	101
2022 Q1	$406K	Buy	4,015 +228	+6%	+$24K	0.04%	72
2021 Q4	$391K	Buy	+3,787	New	+$350K	0.04%	90

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Journey Strategic Wealth's CVS Position: Q1 2026 in Review

Journey Strategic Wealth increased its CVS Health (CVS) stake by 48% in Q1 2026, buying an estimated $246K and bringing the position to 9,844 shares worth $707K. The position accounts for 0.02% of the portfolio, ranked #262.

Journey Strategic Wealth first reported a position in CVS in Q4 2021 and has held it in 11 quarters since. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Journey Strategic Wealth held 9,844 shares of CVS Health worth $707K as of Q1 2026.
Journey Strategic Wealth bought 3,190 CVS Health shares in Q1 2026, an estimated $246K.
CVS Health made up 0.02% of Journey Strategic Wealth's portfolio in Q1 2026, its #262 holding.
Journey Strategic Wealth first reported a position in CVS Health in Q4 2021 and has held it in 11 quarters since.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.